JPRN-UMIN000008242已完成未知
Evaluation of binding property to tau protein, systemic pharmacokinetics and effective dose of [11C]PBB3 - Proper evaluation of [11C]PBB3 as in vivo tau imaging agent
ational Institute of Radiological Sciences0 个研究点目标入组 6 人开始时间: 2012年6月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 88years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1.psychiatric complications such as drug abuse 2.other organic brain complications such as symptomatic stroke, PD-related disorders and other neurodegenrative diseases 3.severe physical complications 4.subject who has metal such as pacemaker in the body, and cannot perform MRI examination 5.subjects with tattoo 6.subject with claustrophobia who cannot perform MRI examination 7.exclude the patients who are recognized as inadequate patients by doctors with resposibility in this study
研究者
相似试验
Unknown
不适用
Tau Protein and SV2a Imaging in Patients With Tau Protein-related DiseasesAlzheimer DiseaseProgressive Supranuclear PalsyFrontotemporal DementiaNCT05260151Xuanwu Hospital, Beijing155
招募中
不适用
Amyloid tau protein and brain structure networkMild cognitive impairment or Alzheime's diseaseAlzheimer disease, cognitive impairmentD000544JPRN-jRCTs031210318Matsuda Hiroshi50
已完成
不适用
Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal DementiaPrimary Progressive AphasiaBehavioral Variant of Frontotemporal DementiaFrontotemporal Dementia, Behavioral VariantNCT02736695Mayo Clinic81
Enrolling By Invitation
不适用
Characterization of Cerebral Tau Aggregates With 18F-RO6958948 PET in the ALFA PopulationHealthyMild Cognitive ImpairmentNCT04482660Barcelonabeta Brain Research Center, Pasqual Maragall Foundation100
已完成
早期 1 期
Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired SubjectsAlzheimer DiseaseNCT04474405Avid Radiopharmaceuticals36